Syschem (India) Limited (BOM:531173)

India · Delayed Price · Currency is INR

30.65

+0.56 (1.86%)

At close: Aug 21, 2026

-33.30% (1Y)

Market Cap	1.64B -17.8%
Revenue (ttm)	6.54B +59.1%
Net Income	75.88M +280.0%
EPS	1.28 +169.1%
Shares Out	53.62M
PE Ratio	23.86
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	33,394
Open	31.40
Previous Close	30.09
Day's Range	29.87 - 31.40
52-Week Range	29.29 - 62.00
Beta	-0.30
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 4, 2026

About Syschem (India)

Syschem (India) Limited engages in the production and sale of active pharmaceuticals ingredients (API), intermediates, bulk drugs, and specialty chemicals in India. Its APIs/intermediates include amoxycillin trihydrate, ampicillin trihydrate, cloxacillin sodium, dicloxacillin sodium, flucloxacillin sodium, cephalexin, and cefadroxil. The company also engages in the distillation of specialty solvents, such as methonel, acetonitrile, ethyl acetate, and THF; and contract manufacturing business. Syschem (India) Limited was incorporated in 1993 and ... [Read more]

Industry Industrial Organic Chemicals

Founded 1993

Employees 115

Stock Exchange Bombay Stock Exchange

Ticker Symbol 531173

Full Company Profile

Financial Performance

In fiscal year 2026, Syschem (India)'s revenue was 6.55 billion, an increase of 69.49% compared to the previous year's 3.86 billion. Earnings were 109.29 million, an increase of 2275.35%.

Financial Statements